A non-geek’s guide to the process of investing In crypto—with a clear understanding of the challenges and risks.

The Company will highlight integrated clinical and genomic insights generated through its Oncology Data Solutions platformFORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading ...

Fulgent Genetics, Inc. ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that its ...

Generative AI needs clear standards and accountability. As the OECD has repeatedly highlighted, AI is transformative but, ...

Issued on behalf of Starfighters Space, Inc. As the post-ISS era approaches, a handful of public-market operators are ...

Recent judicial developments show that courts now accept DNA evidence as highly probative, but they insist much more strongly on chain of custody, proper sampling, laboratory integrity, and ...

An AI-assisted analysis of the gut microbiome in colorectal cancer cases revealed substantial differences between early- and ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary Diffuspheretm technology designed to optimize local, controlled drug ...

Global Environmental Test Chambers Market Research Report: There's a quiet arms race happening inside engineering labs around ...

Around the country, heated debates are taking place over whether to install artificial turf, pitting neighbors against each ...

New 2026 research shows AI altering digital gift card payments through conversational shopping, agent-led checkout, ...

In April 2026, Stanford University’s Human-Centered Artificial Intelligence institute published its annual AI Index Report ...